‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill
bostonglobe.com/2023/03/18/business/well-look-back-say-that-this-was-bargain-takeda-reveals-first-data-its-4-billion-autoimmune-disease-pill 
In an intermediate-stage clinical study of 259 people with moderate-to-severe plaque psoriasis, the highest dose of the daily pill completely cleared itchy and painful patches of skin in one-third of the patients after 12 weeks. “We’re offering the potential for a functional cure,” Andrew Plump, Takeda’s president of research and development, said in an interview.
Doctors and…
This story appeared on bostonglobe.com, 2023-03-18.